Update on pharmacogenetics in cancer chemotherapy (Q34578592)

3 August 2017

1 reference

title

Update on pharmacogenetics in cancer chemotherapy (English)

1 reference

3 August 2017

1 reference

2

Ratain MJ

1 reference

3 August 2017

Innocenti F

1

1 reference

3 August 2017

publication date

1 March 2002

1 reference

European Journal of Cancer

3 August 2017

published in

1 reference

3 August 2017

volume

38

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

639-644

1 reference

Pharmacogenetics: a tool for individualizing antineoplastic therapy

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Segregation analysis of human red blood cell thiopurine methyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

1 reference

7 January 2021

Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Influence of the variable number of tandem repeats located in the promoter region of the thiopurine methyltransferase gene on enzymatic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Genomic structure and multiple single-nucleotide polymorphisms (SNPs) of the thiopurine S-methyltransferase (TPMT) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Known variant DPYD alleles do not explain DPD deficiency in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

The genetic basis of Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

A common methylenetetrahydrofolate reductase gene mutation and longevity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Biological and clinical implications of the MTHFR C677T polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Role in translation of a triple tandemly repeated sequence in the 5'-untranslated region of human thymidylate synthase mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5'-terminal Regulatory Region of the Human Gene for Thymidylate Synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Novel thymidylate synthase enhancer region alleles in African populations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Allelotype of colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Thymidylate synthase promoter polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Structural analysis of cDNA encoding thymidylate synthase in hepatic metastases of human colorectal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Glutathione S-transferase polymorphisms and their biological consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Glutathione-S-transferase family of enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Metabolism of epirubicin to glucuronides: relationship to the pharmacodynamics of the drug.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900434-8

7 January 2021

10.1016/S0959-8049(01)00434-8

Identifiers

DOI

1 reference

3 August 2017

1 reference